DK0425154T3 - Genstande med vedvarende afgivelse af aktivt stof - Google Patents

Genstande med vedvarende afgivelse af aktivt stof

Info

Publication number
DK0425154T3
DK0425154T3 DK90311278.7T DK90311278T DK0425154T3 DK 0425154 T3 DK0425154 T3 DK 0425154T3 DK 90311278 T DK90311278 T DK 90311278T DK 0425154 T3 DK0425154 T3 DK 0425154T3
Authority
DK
Denmark
Prior art keywords
items
active substance
sustained release
sustained
release
Prior art date
Application number
DK90311278.7T
Other languages
Danish (da)
English (en)
Inventor
Louis Michel Jaques Aguadisch
Bernard Francis Grisoni
Alain Etienne
Original Assignee
Dow Corning Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Sa filed Critical Dow Corning Sa
Application granted granted Critical
Publication of DK0425154T3 publication Critical patent/DK0425154T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90311278.7T 1989-10-23 1990-10-16 Genstande med vedvarende afgivelse af aktivt stof DK0425154T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913818A FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.

Publications (1)

Publication Number Publication Date
DK0425154T3 true DK0425154T3 (da) 1993-11-01

Family

ID=9386646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90311278.7T DK0425154T3 (da) 1989-10-23 1990-10-16 Genstande med vedvarende afgivelse af aktivt stof

Country Status (13)

Country Link
EP (1) EP0425154B1 (fr)
JP (1) JPH03167116A (fr)
KR (1) KR910007518A (fr)
AU (1) AU639947B2 (fr)
BR (1) BR9005223A (fr)
CA (1) CA2027865A1 (fr)
DE (1) DE69003347T2 (fr)
DK (1) DK0425154T3 (fr)
ES (1) ES2044451T3 (fr)
FI (1) FI905195A0 (fr)
FR (1) FR2653337B1 (fr)
HU (1) HUT69395A (fr)
IE (1) IE66826B1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
FR2677253A1 (fr) * 1991-06-07 1992-12-11 Union Metropolitaine Pharmaceu Composition therapeutique utile vis-a-vis des maladies inflammatoires du systeme gastro-intestinal.
JP3190340B2 (ja) * 1991-09-24 2001-07-23 アメリカ合衆国 酸化窒素供与体プロドラッグとしての求核試薬−酸化窒素付加物の酸素置換誘導体
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
AU2002225763A1 (en) 2000-11-28 2002-06-11 Fmc Corporation Edible pga(propylene glycol alginate) coating composition
KR100477364B1 (ko) * 2002-07-03 2005-03-22 주식회사 메디켐스 신규한 헬리코박터 파이로리 균 진단용 13ｃ-요소 캅셀 제제
PA8578501A1 (es) 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
SG164375A1 (en) 2004-08-13 2010-09-29 Boehringer Ingelheim Int Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
EA201001083A1 (ru) 2004-08-13 2011-08-30 Бёрингер Ингельхайм Интернациональ Гмбх Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
EP1745775B1 (fr) * 2005-07-19 2008-05-28 Ethypharm Formulations de rétention gastrique et procédé de préparation
WO2007086078A2 (fr) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Compositions pharmaceutiques atypiques et processus de preparation correspondant
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
JP5690398B2 (ja) 2010-04-14 2015-03-25 メンリッケ・ヘルス・ケア・アーベー 抗菌性ゲル
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
GB2492037A (en) 2010-05-10 2012-12-19 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
US9993433B2 (en) 2010-05-10 2018-06-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
GB201020895D0 (en) 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
AU2014350135B2 (en) 2013-11-13 2017-08-31 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
KR101599126B1 (ko) 2014-04-01 2016-03-14 주식회사 명성 스크루식 뚜껑 성형장치
EP4037666B1 (fr) 2020-12-08 2024-05-01 Ruminant Biotech Corp Limited Améliorations apportées à des dispositifs et des méthodes d'administration de substances aux animaux
WO2023148316A1 (fr) * 2022-02-03 2023-08-10 Basf Se Diacétate de magnésium x 4h 2o et/ou dichlorure de magnésium x 6h 2o et/ou sulfate de magnésium x 2o et/ou sulfate disodique x 10 h 2o et/ou thiosulfate de sodium x 5h 2o et/ou na 3po 4 x 12 h 2o et/ou na 2hpo 4 x 12h 2o/7h 2o et/ou acétate de sodium x 3h 2o en tant qu'auxiliaire de granulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3991750A (en) * 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
CA1331338C (fr) * 1987-02-03 1994-08-09 Dow Corning Corporation Compositions aqueuses formant une pellicule, utilisees pour reguler la liberation d'agents actifs, et procede pour leur fabrication
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
AU639947B2 (en) 1993-08-12
CA2027865A1 (fr) 1991-04-24
FR2653337A1 (fr) 1991-04-26
KR910007518A (ko) 1991-05-30
DE69003347T2 (de) 1994-02-17
HUT69395A (en) 1995-09-28
FI905195A0 (fi) 1990-10-22
IE66826B1 (en) 1996-02-07
ES2044451T3 (es) 1994-01-01
DE69003347D1 (de) 1993-10-21
HU906525D0 (en) 1991-04-29
EP0425154A1 (fr) 1991-05-02
BR9005223A (pt) 1991-09-17
AU6486390A (en) 1991-04-26
IE903777A1 (en) 1991-04-24
JPH03167116A (ja) 1991-07-19
FR2653337B1 (fr) 1992-02-07
EP0425154B1 (fr) 1993-09-15

Similar Documents

Publication Publication Date Title
DK0425154T3 (da) Genstande med vedvarende afgivelse af aktivt stof
DK0383569T3 (da) Opbevaring af materialer
KR920011223U (ko) 1회용 착용물품
DK392281A (da) Pestcide midler med langsom frigorelse af den aktive bestanddel
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
LV10086A (lv) CIV - inhibejosi benzolacetamida atvasinajumi
DE69122183D1 (de) Leicht und schnell prüfbare Master-Slave-Kippschaltung
DK386986D0 (da) Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel
DK104389A (da) Anvendelse af imidazolderivater
DK592488D0 (da) Fremgangsmaade til fremstilling af formstabile genstande
DK130390D0 (da) Praeparat af i prokaryonter udtrykt plasminogenaktivator
DK104489D0 (da) Anvendelse af triazolderivater
DK283990D0 (da) Indretning til chargevis tilberedning af styrtgods
NO900009L (no) Fremgangsmaate for fremstilling av aspiringranuler med regulert frigivningseffekt.
DK562289A (da) Anvendelse af somatostatiner
DK229789A (da) Farmaceutiske oploesninger af triamteren
DK326789A (da) Fremstilling af homonojirimycin-derivater
KR940002728U (ko) 의복에 부착되는 찜질팩
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater
FR2646077B1 (fr) Ecarteur statique
BR7002603U (pt) Suporte para roupas
KR920005963U (ko) 1회용 착용 물품
DK98389D0 (da) Formuleringer af liposomale antineoplastiske midler med hoeje medikament-lipid-forhold
IT9036120V0 (it) Struttura di pantaloni perfezionata
NO170994C (no) Forankringsbolt